Malaria Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

COVID-19 Transmission and Morbidity in Malawi
Conditions: SARS CoV 2 Infection; SARS CoV 2 Vaccination Intervention: Sponsors: Boston University; National Institute of Allergy and Infectious Diseases (NIAID); Malaria Alert Center, Kamuzu University of Health Sciences; Burnet Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials

COVID Transmission and Morbidity in Malawi
Conditions: SARS CoV 2 Infection; SARS CoV 2 Vaccination Intervention: Sponsors: Boston University; National Institute of Allergy and Infectious Diseases (NIAID); Malaria Alert Center, Kamuzu University of Health Sciences; Burnet Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials

TES of Artemether-lumefantrine for Pf in the Philippines in 2017-2018
Conditions: Malaria,Falciparum; Malaria Recrudescence Interventions: Drug: Artemether-lumefantrine; Drug: Primaquine Sponsors: Research Institute for Tropical Medicine, Philippines; World Health Organization Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials

TES of Chloroquine for Pv in the Philippines in 2016
Conditions: Malaria; Vivax Malaria; Recrudescence Interventions: Drug: Chloroquine; Drug: Primaquine Sponsors: Research Institute for Tropical Medicine, Philippines; World Health Organization Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials